AU4394396A - Modified peptides - Google Patents

Modified peptides

Info

Publication number
AU4394396A
AU4394396A AU43943/96A AU4394396A AU4394396A AU 4394396 A AU4394396 A AU 4394396A AU 43943/96 A AU43943/96 A AU 43943/96A AU 4394396 A AU4394396 A AU 4394396A AU 4394396 A AU4394396 A AU 4394396A
Authority
AU
Australia
Prior art keywords
modified peptides
peptides
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43943/96A
Other languages
English (en)
Inventor
Alejandro Jose Daniels
Dennis Heyer
Johann Jakob Leban
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of AU4394396A publication Critical patent/AU4394396A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C07K5/06095—Arg-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU43943/96A 1995-01-12 1996-01-12 Modified peptides Abandoned AU4394396A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9500601.1A GB9500601D0 (en) 1995-01-12 1995-01-12 Modified peptides
GB9500601 1995-01-12
PCT/GB1996/000057 WO1996022305A2 (fr) 1995-01-12 1996-01-12 Peptides modifies

Publications (1)

Publication Number Publication Date
AU4394396A true AU4394396A (en) 1996-08-07

Family

ID=10767945

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43943/96A Abandoned AU4394396A (en) 1995-01-12 1996-01-12 Modified peptides

Country Status (3)

Country Link
AU (1) AU4394396A (fr)
GB (1) GB9500601D0 (fr)
WO (1) WO1996022305A2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2814367B1 (fr) * 2000-09-25 2008-12-26 Inst Nat Sante Rech Med Ligands du recepteur npff pour le traitement de la douleur et des hyperalgies
SE0103476D0 (sv) * 2001-10-18 2001-10-18 Markus Heilig New use
JP4806628B2 (ja) 2003-05-05 2011-11-02 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤
AU2004290499C1 (en) 2003-11-03 2011-02-24 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
CA2554809C (fr) 2004-02-05 2014-04-29 Probiodrug Ag Nouveaux inhibiteurs de la glutaminyl-cyclase comportant de la n thiouree alkyle et de l'imidazolyl substitue par thioamide
EP2089383B1 (fr) 2006-11-09 2015-09-16 Probiodrug AG Dérivés 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one utiles en tant qu' inhibiteurs de la glutaminyl-cyclase dans le traitement des ulcères, du cancer et d'autres maladies
DK2091948T3 (da) 2006-11-30 2012-07-23 Probiodrug Ag Nye inhibitorer af glutaminylcyclase
CA2679446C (fr) 2007-03-01 2016-05-17 Probiodrug Ag Nouvelle utilisation d'inhibiteurs de la glutaminyl cyclase
US9656991B2 (en) 2007-04-18 2017-05-23 Probiodrug Ag Inhibitors of glutaminyl cyclase
MX2012002993A (es) 2009-09-11 2012-04-19 Probiodrug Ag Derivados heterociclicos como inhibidores de ciclasa glutaminilo.
WO2011107530A2 (fr) 2010-03-03 2011-09-09 Probiodrug Ag Nouveaux inhibiteurs
JP5688745B2 (ja) 2010-03-10 2015-03-25 プロビオドルグ エージー グルタミニルシクラーゼ（ｑｃ、ｅｃ２．３．２．５）の複素環阻害剤
EP2560953B1 (fr) 2010-04-21 2016-01-06 Probiodrug AG Inhibiteurs de glutaminyl cyclase
ES2570167T3 (es) 2011-03-16 2016-05-17 Probiodrug Ag Derivados de benzimidazol como inhibidores de glutaminil ciclasa
ES2812698T3 (es) 2017-09-29 2021-03-18 Probiodrug Ag Inhibidores de glutaminil ciclasa

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4326465A1 (de) * 1993-01-20 1995-02-09 Thomae Gmbh Dr K Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
WO1996022305A2 (fr) 1996-07-25
WO1996022305A3 (fr) 1996-09-06
GB9500601D0 (en) 1995-03-01

Similar Documents

Publication Publication Date Title
AU7203496A (en) Novel peptides
AU4780896A (en) Core-board
AU1030997A (en) Taphane
AU4996696A (en) 2-benzyl-3-arylbenzothiophenes
AU4427296A (en) Novel peptide
AU4394396A (en) Modified peptides
AU6277796A (en) Urocortin peptides
AU2131195A (en) Prophenins - antibiotic peptides
AU5989696A (en) Tcr vbeta5 peptides
AU4382896A (en) Acetylimidazobenzodiazepines
AU5550296A (en) Conotoxin peptides
AU7520396A (en) Abl-interactor protein
AU1999999A (en) Contryphan peptides
AU5284296A (en) Immune-evading proteins
AU6890696A (en) Peptide derivatives
AU5013796A (en) Wireclamp
AUPM489194A0 (en) Peptides
AU6890596A (en) Peptide derivatives
AU5161296A (en) Anti-haemorrhagic peptides
AU5654096A (en) Antisense peptides
AU6153396A (en) E6ap-binding proteins
AU4569496A (en) Tetralinyl- and indanyl-ethylamides
GB9519511D0 (en) Peptides
AU5699996A (en) Anti-inflammatory thrombospondin-derived peptides
AU6476398A (en) Novel peptides